封面
市場調查報告書
商品編碼
1619304

胰島素筆市場規模、佔有率、成長分析,按類型、最終用途、地區 - 產業預測,2024-2031 年

Insulin Pens Market Size, Share, Growth Analysis, By Type (Reusable Insulin Pens, Disposable Insulin Pens), By End-use (Hospitals & Clinics, Homecare), By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球胰島素筆市場規模為62億美元,從2023年的77.3億美元成長到2031年的448.8億美元,複合年成長率預計為24.6%。

由於糖尿病盛行率不斷上升,以及由於易於使用和方便的輸送方式而擴大採用胰島素筆,全球胰島素筆市場正在強勁成長。這些筆由於其易於使用、劑量準確和便攜而受到越來越多的糖尿病患者的歡迎,特別是在開發中國家。公認的糖尿病管理優勢,以及藍牙連接和資料追蹤功能等技術進步,進一步推動了市場擴張。然而,先進型號的高價格限制了它們在低收入地區的可用性、某些地區的醫療基礎設施不足以及製造商為確保符合品質標準而必須遵守的法規的複雜性等問題仍然存在。應對這些挑戰對於永續市場成長至關重要。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特分析與影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2023)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 技術進步
  • 監管環境
  • 專利分析
  • 案例研究
  • 客戶和購買標準分析

胰島素筆市場規模:按類型

  • 市場概況
  • 可重複使用的胰島素筆
  • 拋棄式胰島素筆

胰島素筆市場規模:依最終用途分類

  • 市場概況
  • 醫院/診所
  • 居家護理
  • 其他

胰島素筆市場規模:按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Ypsomed Holding AG
  • BD(Becton, Dickinson and Company)
  • Owen Mumford Ltd
  • Haselmeier AG
  • Medtronic plc
  • Emperra GmbH E-Health Technologies
  • Diamesco Co., Ltd.
  • MANNKind Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Pendiq GmbH
  • Sensile Medical AG
  • Injex Pharma AG
  • Copernicus Sp. z oo
  • Wockhardt Ltd

結論和建議

簡介目錄
Product Code: SQMIG35B2138

Global Insulin Pens Market size was valued at USD 6.2 billion in 2022 and is poised to grow from USD 7.73 billion in 2023 to USD 44.88 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global insulin pens market is experiencing robust growth, driven by the rising prevalence of diabetes and the increasing adoption of insulin pens for their user-friendly and convenient delivery method. These pens are favored for their ease of use, precise dosing, and portability, particularly among the growing diabetic population in developing countries. Awareness of their benefits in diabetes management, alongside technological advancements-such as Bluetooth connectivity and data tracking features-has further propelled market expansion. However, challenges remain, including high costs of advanced models limiting accessibility in low-income regions, inadequate healthcare infrastructure in some areas, and regulatory complexities that manufacturers must navigate to ensure compliance with quality standards. Addressing these challenges is critical for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

Global Insulin Pens Market is segmented by Type, End-use, and region. Based on Type, the market is segmented into Reusable Insulin Pens, and Disposable Insulin Pens. Based on End-use, the market is segmented into Hospitals & Clinics, Homecare, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pens Market

The Global Insulin Pens market is significantly propelled by ongoing technological advancements within insulin pen devices. Innovations such as Bluetooth connectivity, built-in memory functions, and the emergence of smart insulin pens contribute to an enhanced user experience and more effective treatment outcomes. These modern features not only make it easier for patients to manage their diabetes but also promote adherence to treatment regimens. As patients increasingly seek devices that offer both convenience and functionality, these technological improvements are expected to fuel market growth, making insulin pens more appealing and accessible to a wider range of consumers.

Restraints in the Global Insulin Pens Market

The Global Insulin Pens market faces certain constraints primarily due to needle phobia and resistance among some individuals. This aversion to needles can significantly hinder the acceptance and utilization of insulin pens, as many people experience anxiety or fear associated with self-injection. Such apprehensions often lead to decreased adherence to treatment regimens and a preference for alternative methods of insulin delivery. Consequently, the presence of needle-related fears may result in an overall reluctance to adopt insulin pens, posing challenges for market growth and the effective management of diabetes among affected individuals.

Market Trends of the Global Insulin Pens Market

The Global Insulin Pens market is witnessing a significant trend towards customization and personalization, driven by the increasing demand for products that cater to individual patient needs. Manufacturers are responding by offering a variety of options, including a spectrum of colors, adjustable dose settings, and personalized branding features. This movement not only aims to enhance patient engagement and satisfaction but also fosters a sense of ownership among users, making insulin management more user-friendly. As awareness of diabetes continues to rise globally, the push for tailored solutions is expected to dominate the market, influencing product development and healthcare strategies in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies
  • Customer & Buying Criteria Analysis

Global Insulin Pens Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Reusable Insulin Pens
  • Disposable Insulin Pens

Global Insulin Pens Market Size by End-use & CAGR (2024-2031)

  • Market Overview
  • Hospitals & Clinics
  • Homecare
  • Others

Global Insulin Pens Market Size & CAGR (2024-2031)

  • North America, (Type, End-use)
    • US
    • Canada
  • Europe, (Type, End-use)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Type, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Type, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Type, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Novo Nordisk A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Owen Mumford Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haselmeier AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Emperra GmbH E-Health Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diamesco Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MANNKind Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jiangsu Delfu Medical Device Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pendiq GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sensile Medical AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Injex Pharma AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Copernicus Sp. z o.o.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wockhardt Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation